Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 652

  • Showing results for a modified search because your search retrieved no results.

Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.

Pietrasik G, Goldenberg I, McNitt S, Moss AJ, Zareba W.

J Cardiovasc Electrophysiol. 2007 Feb;18(2):181-4.


Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.

Choy B, Hansen E, Moss AJ, McNitt S, Zareba W, Goldenberg I; Multicenter Automatic Defibrillator Implantation Trial-II Investigators.

Am J Cardiol. 2010 Mar 1;105(5):581-6. doi: 10.1016/j.amjcard.2009.10.041. Epub 2010 Jan 22.


Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).

Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, Moss AJ; MADIT-II Investigators.

J Am Coll Cardiol. 2005 Nov 1;46(9):1712-20. Epub 2005 Oct 10.


Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

Vyas AK, Guo H, Moss AJ, Olshansky B, McNitt SA, Hall WJ, Zareba W, Steinberg JS, Fischer A, Ruskin J, Andrews ML; MADIT-II Research Group.

J Am Coll Cardiol. 2006 Feb 21;47(4):769-73. Epub 2006 Jan 30. Erratum in: J Am Coll Cardiol. 2006 Apr 18;47(8):1739.


Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.

Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, Dick A, Daubert JP, Zareba W, Moss AJ; MADIT-II Research Group.

J Cardiovasc Electrophysiol. 2007 Aug;18(8):833-8. Epub 2007 May 30.


Are MADIT II criteria for implantable cardioverter defibrillator implantation appropriate for Chinese patients?

Siu CW, Pong V, Ho HH, Liu S, Lau CP, Li SW, Tse HF.

J Cardiovasc Electrophysiol. 2010 Mar;21(3):231-5. doi: 10.1111/j.1540-8167.2009.01609.x. Epub 2009 Oct 5.


Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.

Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ.

J Am Coll Cardiol. 1999 May;33(6):1596-601.


Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses.

Pires LA, Lehmann MH, Steinman RT, Baga JJ, Schuger CD.

J Am Coll Cardiol. 1999 Jan;33(1):24-32.


Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.

Lepillier A, Piot O, Gerritse B, Copie X, Lavergne T, Paziaud O, Lascault G, Waintraub X, Otmani A, Le Heuzey JY.

Europace. 2009 Jan;11(1):80-5. doi: 10.1093/europace/eun288. Epub 2008 Oct 24.


QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.

Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ; Multicenter Automatic Defibrillator Implantation Trial II investigators.

J Am Coll Cardiol. 2004 Oct 6;44(7):1481-7.


Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.

Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ; MADIT II Study Investigators.

J Am Coll Cardiol. 2006 Jan 3;47(1):98-107. Epub 2005 Dec 15.


Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction.

Zareba W, Moss AJ, Jackson Hall W, Wilber DJ, Ruskin JN, McNitt S, Brown M, Wang H; MADIT II Investigators.

J Cardiovasc Electrophysiol. 2005 Dec;16(12):1265-70.


Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.

Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML; MADIT-II Investigators.

J Am Coll Cardiol. 2008 Jan 22;51(3):288-96. doi: 10.1016/j.jacc.2007.08.058.


Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.

Whang W, Mittleman MA, Rich DQ, Wang PJ, Ruskin JN, Tofler GH, Muller JE, Albert CM; TOVA Investigators.

Circulation. 2004 Mar 23;109(11):1386-91. Epub 2004 Mar 1.


Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.

Cardinalli-Neto A, Bestetti RB, Cordeiro JA, Rodrigues VC.

J Cardiovasc Electrophysiol. 2007 Dec;18(12):1236-40. Epub 2007 Sep 26.


Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II.

Berenbom LD, Weiford BC, Vacek JL, Emert MP, Hall WJ, Andrews ML, McNitt S, Zareba W, Moss AJ.

Ann Noninvasive Electrocardiol. 2005 Oct;10(4):429-35.


Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator.

Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD; Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group.

Circulation. 2004 Dec 21;110(25):3760-5. Epub 2004 Dec 6.


Prognostic significance of nonsustained ventricular tachycardia after revascularization.

Mittal S, Lomnitz DJ, Mirchandani S, Stein KM, Markowitz SM, Slotwiner DJ, Iwai S, Das MK, Lerman BB.

J Cardiovasc Electrophysiol. 2002 Apr;13(4):342-6.


Supplemental Content

Support Center